chr3-195868158-T-C
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_001382273.1(TNK2):c.2140A>G(p.Ser714Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000577 in 1,610,782 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001382273.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TNK2 | NM_001382273.1 | c.2140A>G | p.Ser714Gly | missense_variant | 13/16 | ENST00000672887.2 | NP_001369202.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TNK2 | ENST00000672887.2 | c.2140A>G | p.Ser714Gly | missense_variant | 13/16 | NM_001382273.1 | ENSP00000499899 |
Frequencies
GnomAD3 genomes AF: 0.000309 AC: 47AN: 151986Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000967 AC: 23AN: 237760Hom.: 0 AF XY: 0.0000689 AC XY: 9AN XY: 130586
GnomAD4 exome AF: 0.0000315 AC: 46AN: 1458678Hom.: 0 Cov.: 51 AF XY: 0.0000234 AC XY: 17AN XY: 725612
GnomAD4 genome AF: 0.000309 AC: 47AN: 152104Hom.: 0 Cov.: 33 AF XY: 0.000363 AC XY: 27AN XY: 74374
ClinVar
Submissions by phenotype
not specified Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2021 | The c.2329A>G (p.S777G) alteration is located in exon 13 (coding exon 13) of the TNK2 gene. This alteration results from a A to G substitution at nucleotide position 2329, causing the serine (S) at amino acid position 777 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 11, 2023 | This sequence change replaces serine, which is neutral and polar, with glycine, which is neutral and non-polar, at codon 777 of the TNK2 protein (p.Ser777Gly). This variant is present in population databases (rs139797100, gnomAD 0.2%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with TNK2-related conditions. ClinVar contains an entry for this variant (Variation ID: 259874). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at